Paper Citation Record · LEDGER

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties

As of 19 August 2026, this Paper Citation Record lists 37 of 37 outbound references and 0 inbound Pith citation observations for arXiv:2506.03050.

A citation records a reference. It does not transfer a finding from one paper to another.

pith.paper-citation-record.v1
2506.03050 v1

Coverage vector

measured 37 of 37 reference resolution

Typed states for the displayed outbound observations.

Source: paper_references, paper_reference_links, observed 2026-08-07T11:21:20.870837Z

measured 37 of 37 standing notices

One-hop event checks from named stored sources.

Source: scholarly_work_events, retraction_status_cache, observed 2026-08-19T06:32:44.657259+00:00

measured 0 of 0 inbound itemization

Pith citing papers itemized under the disclosed page cap.

Source: paper_references, paper_reference_links

measured 0 of 1 external citation measurements

A source-named dated measurement, never combined with another source.

Source: cited_works

Reference resolution

37 of 37 outbound references displayed

verified exact0
verified fuzzy23
unresolved14
parse uncertain0
malformed identifier0
metadata mismatch0

External citation measurements

No source-named external measurement is stored.

Outbound references

Observation 3bc4a751-3e1c-489e-9251-023d0c860649 · outbound

This paper cites ://www.fda.gov/media/162416/download, available from: https://www.fda.gov/media/162416/download [Accessed 11th March 2024].

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties ://www.fda.gov/media/162416/download, available from: https://www.fda.gov/media/162416/download [Accessed 11th March 2024]

Reference 1

Resolution: verified fuzzy; raw_fallback, observed 2026-08-07T11:21:21.158941Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

Observation 3083a1ea-2fa8-45ed-8248-71e0ed6bf2ae · outbound

This paper cites Composite outcomes in randomized trials: greater precision but with greater uncertainty? JAMA 2003;289(19):2554--2559.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties Composite outcomes in randomized trials: greater precision but with greater uncertainty? JAMA 2003;289(19):2554--2559

Reference 2

Resolution: verified fuzzy; raw_fallback, observed 2026-08-07T11:21:21.150381Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

Observation e44a426e-40a4-4a1e-b235-773071480b88 · outbound

This paper cites The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities

Reference 3

Resolution: verified fuzzy; raw_fallback, observed 2026-08-07T11:21:21.141335Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

Observation 983576df-1f5f-42ee-a29a-d9c0cbc65e5c · outbound

This paper cites Generalized pairwise comparisons of prioritized outcomes in the two-sample problem.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties Generalized pairwise comparisons of prioritized outcomes in the two-sample problem

Reference 4

Resolution: verified fuzzy; raw_fallback, observed 2026-08-07T11:21:21.133774Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

Observation 5471d2ad-ed38-493f-a687-39098454b36e · outbound

This paper cites The win ratio: on interpretation and handling of ties.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties The win ratio: on interpretation and handling of ties

Reference 5

Resolution: verified fuzzy; raw_fallback, observed 2026-08-07T11:21:21.125650Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

Observation d92b2f11-25d4-4fd9-b064-a2027b83f8b8 · outbound

This paper cites Win odds: An adaptation of the win ratio to include ties.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties Win odds: An adaptation of the win ratio to include ties

Reference 6

Resolution: verified fuzzy; raw_fallback, observed 2026-08-07T11:21:21.116338Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

Observation c5d168da-d437-4a1b-8926-a39d28a053ca · outbound

This paper cites An alternative approach to confidence interval estimation for the win ratio statistic.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties An alternative approach to confidence interval estimation for the win ratio statistic

Reference 7

Resolution: verified fuzzy; raw_fallback, observed 2026-08-07T11:21:21.109123Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

Observation 084d49e8-390b-43c9-9499-c4f48eeb49c3 · outbound

This paper cites Large sample inference for a win ratio analysis of a composite outcome based on prioritized components.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties Large sample inference for a win ratio analysis of a composite outcome based on prioritized components

Reference 8

Resolution: verified fuzzy; raw_fallback, observed 2026-08-07T11:21:21.101073Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

Observation c0885589-9ac2-42ac-ae79-878fcd3f5ecc · outbound

This paper cites On the win-ratio statistic in clinical trials with multiple types of event.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties On the win-ratio statistic in clinical trials with multiple types of event

Reference 9

Resolution: verified fuzzy; raw_fallback, observed 2026-08-07T11:21:21.093818Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

Observation dd35fa49-2901-491e-ae05-6a803eb42e99 · outbound

This paper cites Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial

Reference 10

Resolution: verified fuzzy; raw_fallback, observed 2026-08-07T11:21:21.086892Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

Observation ec4d0641-658a-4a9e-b96a-2c2ef5b5419b · outbound

This paper cites an unresolved cited work.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties Unresolved cited work

Reference 11

Resolution: unresolved; raw_fallback, observed 2026-08-07T11:21:21.078899Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

Observation 97a53203-2c71-4542-b142-b2f2d63fee04 · outbound

This paper cites On recurrent-event win ratio.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties On recurrent-event win ratio

Reference 12

Resolution: verified fuzzy; raw_fallback, observed 2026-08-07T11:21:21.070950Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

Observation cf57e4b5-a40a-409f-9dcc-ac5c77a49630 · outbound

This paper cites The win ratio: Impact of censoring and follow-up time and use with nonproportional hazards.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties The win ratio: Impact of censoring and follow-up time and use with nonproportional hazards

Reference 13

Resolution: verified fuzzy; raw_fallback, observed 2026-08-07T11:21:21.063073Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

Observation 4dc118ed-2869-4d09-b376-df2e067e9378 · outbound

This paper cites The inverse-probability-of-censoring weighting ( IPCW ) adjusted win ratio statistic: An unbiased estimator in the presence of independent censoring.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties The inverse-probability-of-censoring weighting ( IPCW ) adjusted win ratio statistic: An unbiased estimator in the presence of independent censoring

Reference 14

Resolution: verified fuzzy; raw_fallback, observed 2026-08-07T11:21:21.054427Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

Observation 76722439-154c-4bfb-b91f-c1bfdfed1d96 · outbound

This paper cites Adjusting win statistics for dependent censoring.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties Adjusting win statistics for dependent censoring

Reference 15

Resolution: verified fuzzy; raw_fallback, observed 2026-08-07T11:21:21.045764Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

Observation b318705a-edba-42e9-a60d-0522349af218 · outbound

This paper cites Win-loss parameters for right-censored event data, with application to recurrent events.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties Win-loss parameters for right-censored event data, with application to recurrent events

Reference 16

Resolution: verified fuzzy; raw_fallback, observed 2026-08-07T11:21:21.036729Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

Observation eb16dec3-b54a-4779-b1e4-d9be99d6eb0a · outbound

This paper cites Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis

Reference 17

Resolution: verified fuzzy; raw_fallback, observed 2026-08-07T11:21:21.026459Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

Observation 562fd213-ee08-4d1b-b705-b7d59db14d16 · outbound

This paper cites On the empirical choice of the time window for restricted mean survival time.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties On the empirical choice of the time window for restricted mean survival time

Reference 18

Resolution: verified fuzzy; raw_fallback, observed 2026-08-07T11:21:21.017225Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

Observation e9f311dc-b9dc-4d69-8319-380a64f1c4c6 · outbound

This paper cites Utilizing restricted mean duration of response for efficacy evaluation of cancer treatments.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties Utilizing restricted mean duration of response for efficacy evaluation of cancer treatments

Reference 19

Resolution: verified fuzzy; raw_fallback, observed 2026-08-07T11:21:21.008226Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

Observation 03d5ee6a-af30-4309-bb02-fb3562151482 · outbound

This paper cites Avelumab plus axitinib versus sunitinib for advanced renal-cell carcinoma.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties Avelumab plus axitinib versus sunitinib for advanced renal-cell carcinoma

Reference 20

Resolution: verified fuzzy; raw_fallback, observed 2026-08-07T11:21:20.999518Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

Observation e001bcd1-51e5-4a47-b936-3d5e026fc4ab · outbound

This paper cites Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma

Reference 21

Resolution: verified fuzzy; raw_fallback, observed 2026-08-07T11:21:20.989142Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

Observation 8933dbfa-11e3-497f-bf42-124702b7b460 · outbound

This paper cites When you look matters: the effect of assessment schedule on progression-free survival.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties When you look matters: the effect of assessment schedule on progression-free survival

Reference 22

Resolution: verified fuzzy; raw_fallback, observed 2026-08-07T11:21:20.978994Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

Observation 5aeb6b79-042e-4606-9cb9-bf9301f7648a · outbound

This paper cites American Society of Clinical Oncology perspective: raising the bar for clinical trials by defining clinically meaningful outcomes.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties American Society of Clinical Oncology perspective: raising the bar for clinical trials by defining clinically meaningful outcomes

Reference 23

Resolution: verified fuzzy; raw_fallback, observed 2026-08-07T11:21:20.970368Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

Observation 97114303-d106-4f09-a087-dc8ee7b171cb · outbound

This paper cites Treatment selections using risk--benefit profiles based on data from comparative randomized clinical trials with multiple endpoints.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties Treatment selections using risk--benefit profiles based on data from comparative randomized clinical trials with multiple endpoints

Reference 24

Resolution: verified fuzzy; raw_fallback, observed 2026-08-07T11:21:20.960672Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

Observation 6f9a3c60-ae35-42d5-ae3f-7ef48b6b6175 · outbound

This paper cites an unresolved cited work.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties Unresolved cited work

Reference 25

Resolution: unresolved; raw_fallback, observed 2026-08-07T11:21:20.949729Z

Source-reported events for the cited work

No event found in the named queried sources as of 2026-08-19T06:32:44.657259+00:00.

Observation 4d0c1927-eacf-4b46-a408-ccc6bcf57078 · outbound

This paper cites write newline.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties write newline

Reference 26

Resolution: unresolved; no resolver link, observed 2026-08-07T11:21:20.836226Z

Source-reported events for the cited work

Unavailable: canonical work link unavailable.

Observation df1ab362-b400-47a7-aa80-c5783cfeecd6 · outbound

This paper cites , " * write output.state after.block = add.period write newline.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties , " * write output.state after.block = add.period write newline

Reference 27

Resolution: unresolved; no resolver link, observed 2026-08-07T11:21:20.839458Z

Source-reported events for the cited work

Unavailable: canonical work link unavailable.

Observation 7e0042b1-d871-4041-8249-68d0bcb6ee63 · outbound

This paper cites write newline.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties write newline

Reference 28

Resolution: unresolved; no resolver link, observed 2026-08-07T11:21:20.842807Z

Source-reported events for the cited work

Unavailable: canonical work link unavailable.

Observation c931f794-8abf-46e6-8e37-93cb34e16883 · outbound

This paper cites write newline.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties write newline

Reference 29

Resolution: unresolved; no resolver link, observed 2026-08-07T11:21:20.845780Z

Source-reported events for the cited work

Unavailable: canonical work link unavailable.

Observation d05b341c-4a74-4f9b-988f-07f858f8a15d · outbound

This paper cites write newline.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties write newline

Reference 30

Resolution: unresolved; no resolver link, observed 2026-08-07T11:21:20.848655Z

Source-reported events for the cited work

Unavailable: canonical work link unavailable.

Observation 8e62d2bc-194b-42f9-9b04-fe96b677f207 · outbound

This paper cites write newline.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties write newline

Reference 31

Resolution: unresolved; no resolver link, observed 2026-08-07T11:21:20.851928Z

Source-reported events for the cited work

Unavailable: canonical work link unavailable.

Observation dc9d6f14-17d6-44db-aeec-743a159c078b · outbound

This paper cites , " * write output.state after.block = add.period write newline.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties , " * write output.state after.block = add.period write newline

Reference 32

Resolution: unresolved; no resolver link, observed 2026-08-07T11:21:20.855947Z

Source-reported events for the cited work

Unavailable: canonical work link unavailable.

Observation 02fa08af-0fdb-4352-b321-716ff9688b2d · outbound

This paper cites write newline.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties write newline

Reference 33

Resolution: unresolved; no resolver link, observed 2026-08-07T11:21:20.859373Z

Source-reported events for the cited work

Unavailable: canonical work link unavailable.

Observation 6466451d-66f5-4dfa-ab7c-3cc6e3caf4fb · outbound

This paper cites write newline.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties write newline

Reference 34

Resolution: unresolved; no resolver link, observed 2026-08-07T11:21:20.862106Z

Source-reported events for the cited work

Unavailable: canonical work link unavailable.

Observation de63131d-f549-4f22-b9e6-3a27246d20cb · outbound

This paper cites write newline.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties write newline

Reference 35

Resolution: unresolved; no resolver link, observed 2026-08-07T11:21:20.864966Z

Source-reported events for the cited work

Unavailable: canonical work link unavailable.

Observation 88573247-5cee-4e99-8c39-833e4302d03c · outbound

This paper cites Available from:.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties Available from:

Reference 36

Resolution: unresolved; no resolver link, observed 2026-08-07T11:21:20.868059Z

Source-reported events for the cited work

Unavailable: canonical work link unavailable.

Observation e4280ba1-09a2-4519-b71e-659f3556e57c · outbound

This paper cites write newline.

An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties write newline

Reference 37

Resolution: unresolved; no resolver link, observed 2026-08-07T11:21:20.870837Z

Source-reported events for the cited work

Unavailable: canonical work link unavailable.

Pith citing papers

No inbound Pith citation observations are available.